Clinical Trial: Development of an Ultrasensitive Detection System for the Human Myeloid Tumor Marker Gene WT1 and Establishment of Its Reference Range (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of an Ultrasensitive Detection System for the Human Myeloid Tumor Marker Gene WT1 and Establishment of Its Reference Range'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131717

Registration Time: 2026/09/06

Type: Observational study

Primary Sponsor: Beijing Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=263273

Published by HT Digital Content Services with permission from Health Daily Digest....